Epidemiological profile and north-south gradient driving baseline systemic involvement of primary Sjögren's syndrome
- PMID: 31873754
- DOI: 10.1093/rheumatology/kez578
Epidemiological profile and north-south gradient driving baseline systemic involvement of primary Sjögren's syndrome
Abstract
Objective: To characterize the systemic phenotype of primary Sjögren's syndrome at diagnosis by analysing the EULAR-SS disease activity index (ESSDAI) scores.
Methods: The Sjögren Big Data Consortium is an international, multicentre registry based on worldwide data-sharing cooperative merging of pre-existing databases from leading centres in clinical research in Sjögren's syndrome from the five continents.
Results: The cohort included 10 007 patients (9352 female, mean 53 years) with recorded ESSDAI scores available. At diagnosis, the mean total ESSDAI score was 6.1; 81.8% of patients had systemic activity (ESSDAI score ≥1). Males had a higher mean ESSDAI (8.1 vs 6.0, P < 0.001) compared with females, as did patients diagnosed at <35 years (6.7 vs 5.6 in patients diagnosed at >65 years, P < 0.001). The highest global ESSDAI score was reported in Black/African Americans, followed by White, Asian and Hispanic patients (6.7, 6.5, 5.4 and 4.8, respectively; P < 0.001). The frequency of involvement of each systemic organ also differed between ethnic groups, with Black/African American patients showing the highest frequencies in the lymphadenopathy, articular, peripheral nervous system, CNS and biological domains, White patients in the glandular, cutaneous and muscular domains, Asian patients in the pulmonary, renal and haematological domains and Hispanic patients in the constitutional domain. Systemic activity measured by the ESSDAI, clinical ESSDAI (clinESSDAI) and disease activity states was higher in patients from southern countries (P < 0.001).
Conclusion: The systemic phenotype of primary Sjögren's syndrome is strongly influenced by personal determinants such as age, gender, ethnicity and place of residence, which are key geoepidemiological players in driving the expression of systemic disease at diagnosis.
Keywords: ethnicity; gender; geoepidemiology; phenotype; primary Sjögren’s syndrome.
© The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Similar articles
-
Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium.Ann Rheum Dis. 2017 Jun;76(6):1042-1050. doi: 10.1136/annrheumdis-2016-209952. Epub 2016 Nov 29. Ann Rheum Dis. 2017. PMID: 27899373
-
Systemic involvement in primary Sjogren's syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry).Rheumatology (Oxford). 2014 Feb;53(2):321-31. doi: 10.1093/rheumatology/ket349. Epub 2013 Oct 25. Rheumatology (Oxford). 2014. PMID: 24162151
-
Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients.Clin Exp Rheumatol. 2019 May-Jun;37 Suppl 118(3):97-106. Epub 2019 Aug 28. Clin Exp Rheumatol. 2019. PMID: 31464664
-
Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements.Rheumatology (Oxford). 2015 Dec;54(12):2230-8. doi: 10.1093/rheumatology/kev200. Epub 2015 Jul 31. Rheumatology (Oxford). 2015. PMID: 26231345 Free PMC article.
-
EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome.Ann Rheum Dis. 2010 Jun;69(6):1103-9. doi: 10.1136/ard.2009.110619. Epub 2009 Jun 28. Ann Rheum Dis. 2010. PMID: 19561361 Free PMC article.
Cited by
-
Prediction of Sjögren's disease diagnosis using matched electronic dental-health record data.BMC Med Inform Decis Mak. 2024 Feb 9;24(1):43. doi: 10.1186/s12911-024-02448-9. BMC Med Inform Decis Mak. 2024. PMID: 38336735 Free PMC article.
-
Estimated prevalence, incidence and healthcare costs of Sjögren's syndrome in France: a national claims-based study.RMD Open. 2024 Feb 2;10(1):e003591. doi: 10.1136/rmdopen-2023-003591. RMD Open. 2024. PMID: 38307699 Free PMC article.
-
CXCL9 may serve as a potential biomarker for primary Sjögren's syndrome with extra-glandular manifestations.Arthritis Res Ther. 2024 Jan 17;26(1):26. doi: 10.1186/s13075-023-03229-x. Arthritis Res Ther. 2024. PMID: 38229121 Free PMC article.
-
Epidemiology of Sjögren syndrome.Nat Rev Rheumatol. 2024 Mar;20(3):158-169. doi: 10.1038/s41584-023-01057-6. Epub 2023 Dec 18. Nat Rev Rheumatol. 2024. PMID: 38110617 Review.
-
Epidemiology of Sjögren's: A Systematic Literature Review.Rheumatol Ther. 2024 Feb;11(1):1-17. doi: 10.1007/s40744-023-00611-8. Epub 2023 Nov 10. Rheumatol Ther. 2024. PMID: 37948031 Free PMC article. Review.